| Authors: |
Nelson A; Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK., Stewart CJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Kennedy NA; IBD Pharmacogenetics Group, University of Exeter, Exeter, UK.; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Lodge JK; Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK., Tremelling M; Department of Gastroenterology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Probert CS; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.; Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Parkes M; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Mansfield JC; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Smith DL; Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK., Hold GL; Gastrointestinal Research Group, University of Aberdeen, Aberdeen, UK.; Microbiome Research Centre, St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia., Lees CW; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK., Bridge SH; Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Lamb CA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. |
